EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Specific inhibition of α‐synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS

Laurène Adam, Rakesh Kumar iD, Luis Enrique Arroyo-Garcia, Willem Hendrik Molenkamp, Jan Stanislaw Nowak, Hannah Klute, Azad Farzadfard, Rami Alkenayeh, Janni Nielsen, Henrik Biverstål, Daniel E Otzen, Jan Johansson iD and 1 more

Protein Science · 2024-08 · 33 (8)

DOI: 10.1002/pro.5091 ↗

At a glance

Journal article in Protein Science, published online on 2024-07-09. Written by Laurène Adam and 12 co-authors. Institution: Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden. Major MEDLINE topics: alpha-Synuclein, Molecular Chaperones. Cited 12 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: FORMAS, Swedish Society for Medical Research, Alzheimer Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Protein misfolding and aggregation are involved in several neurodegenerative disorders, such as α‐synuclein (αSyn) implicated in Parkinson's disease, where new therapeutic approaches remain essential to combat these devastating diseases. Elucidating the microscopic nucleation mechanisms has opened new opportunities to develop therapeutics against toxic mechanisms and species. Here, we show that naturally occurring molecular chaperones, represented by the anti‐amyloid Bri2 BRICHOS domain, can be used to target αSyn‐associated nucleation processes and structural species related to neurotoxicity. Our findings revealed that BRICHOS predominantly suppresses the formation of new nucleation units on the fibrils surface (secondary nucleation), decreasing the oligomer generation rate. Further, BRICHOS directly binds to oligomeric αSyn species and effectively diminishes αSyn fibril‐related toxicity. Hence, our studies show that molecular chaperones can be utilized as tools to target molecular processes and structural species related to αSyn neurotoxicity and have the potential as protein‐based treatments against neurodegenerative disorders.

Subjects

MeSH terms (MEDLINE)

alpha-SynucleinMolecular ChaperonesHumansAdaptor Proteins, Signal TransducingProtein Domains

Author keywords

BRICHOS domainmolecular chaperoneprotein aggregationα‐Synuclein

Substances

alpha-SynucleinMolecular ChaperonesAdaptor Proteins, Signal TransducingITM2B protein, human

Authors and institutions

  • Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
  • Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.
  • Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C, Denmark.
  • Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.

ORCID profiles: Rakesh Kumar, Jan Johansson, Axel Abelein

Funding

  • FORMAS
  • Swedish Society for Medical Research
  • Alzheimer Foundation
  • Åke Wiberg Foundation
  • Magnus Bergvall Foundation
  • Åhlen Foundation
  • KI Research Foundation
  • Foundation for Geriatric Diseases KI

Cite

APA

Adam, L., Kumar, R., Arroyo-Garcia, L. E., Molenkamp, W. H., Nowak, J. S., Klute, H., Farzadfard, A., Alkenayeh, R., Nielsen, J., Biverstål, H., Otzen, D. E., Johansson, J., & Abelein, A. (2024). Specific inhibition of α‐synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS. Protein Science, 33(8). https://doi.org/10.1002/pro.5091

Vancouver

Adam L, Kumar R, Arroyo-Garcia LE, Molenkamp WH, Nowak JS, Klute H, et al. Specific inhibition of α‐synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS. Protein Science. 2024;33(8). doi:10.1002/pro.5091

BibTeX
@article{Adam2024,
  author = {Adam, Laurène and Kumar, Rakesh and Arroyo-Garcia, Luis Enrique and Molenkamp, Willem Hendrik and Nowak, Jan Stanislaw and Klute, Hannah and Farzadfard, Azad and Alkenayeh, Rami and Nielsen, Janni and Biverstål, Henrik and Otzen, Daniel E and Johansson, Jan and Abelein, Axel},
  title = {Specific inhibition of α‐synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS},
  journal = {Protein Science},
  year = {2024},
  volume = {33},
  number = {8},
  doi = {10.1002/pro.5091}
}
Start for free →